Xiang‐mei Wen
- Hematology top 2%
- Acute Myeloid Leukemia Research 56
- Chronic Myeloid Leukemia Treatments 5
- Cancer Research top 5%
- MicroRNA in disease regulation 11
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 30
- Cancer-related gene regulation 11
- Histone Deacetylase Inhibitors Research 10
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Hemoglobinopathies and Related Disorders 6
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiang‐mei Wen
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Hematology 586
- Cancer Research 368
- Molecular Biology 847
- Genetics 123
- Immunology 161
Countries citing papers authored by Xiang‐mei Wen
This map shows the geographic impact of Xiang‐mei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang‐mei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang‐mei Wen more than expected).
Fields of papers citing papers by Xiang‐mei Wen
This network shows the impact of papers produced by Xiang‐mei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang‐mei Wen. The network helps show where Xiang‐mei Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiang‐mei Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 3 | |
| 6 | 2020 | 28 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 32 | |
| 10 | 2019 | 60 | |
| 11 | 2018 | 11 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 25 | |
| 14 | 2017 | 24 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 19 | |
| 17 | 2016 | 12 | |
| 18 | 2015 | 6 | |
| 19 | 2015 | 32 | |
| 20 | 2014 | 41 |
About Xiang‐mei Wen
Xiang‐mei Wen is a scholar working on Hematology, Genetics and Cancer Research, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (56 papers), Epigenetics and DNA Methylation (30 papers), MicroRNA in disease regulation (11 papers), Cancer-related gene regulation (11 papers), Histone Deacetylase Inhibitors Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (586 citations), Cancer Research (368 citations) and Molecular Biology (847 citations). Xiang‐mei Wen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jiang Lin, Ji‐chun Ma, Jun Qian, Jing‐dong Zhou, Zi‐jun Xu, Ting‐juan Zhang, Zhaoqun Deng, Hong Guo, Lei Yang and Jun Qian. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.